HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical parameters for predicting response to lumbar sympathectomy in patients with severe lower limb ischemia.

Abstract
A prospective study of 85 lumbar sympathectomies for inoperable peripheral vascular disease was conducted to analyze the correlation between lumbar sympathectomy, ankle/arm index (AAI), popliteal-brachial index (PBI), and the clinical presentation; and to study if predicted clinical criteria, single or combined, could be defined for selection of patients who might benefit from lumbar sympathectomy. Good results were obtained if at six months after surgery pain at rest was absent, ischemic ulcers had healed, and there were no major amputations. Seventy-seven percent of all limbs with a preoperative AAI greater than or equal to 0.3 had a good outcome in contrast to 94% failure for index less than 0.3 (p = .000000477). Sixty-nine percent of all limbs with PBI greater than or equal to 0.7 had a good outcome vs. 52% if index less than 0.7 (p = 0.199). Patients with rest pain, simple leg ulcers, and toe gangrene had a good outcome if the AAI greater than or equal to 0.3 and if the postoperative AAI increased by greater than or equal to 0.1. The PBI and diabetic status had no prognostic value.
AuthorsA F AbuRahma, P A Robinson
JournalThe Journal of cardiovascular surgery (J Cardiovasc Surg (Torino)) 1990 Jan-Feb Vol. 31 Issue 1 Pg. 101-6 ISSN: 0021-9509 [Print] Italy
PMID2324170 (Publication Type: Comparative Study, Journal Article)
Topics
  • Adult
  • Aged
  • Amputation, Surgical
  • Ankle (blood supply)
  • Arm (blood supply)
  • Brachial Artery (physiopathology)
  • Diabetes Complications
  • Diabetes Mellitus (physiopathology)
  • Female
  • Foot (pathology)
  • Gangrene
  • Humans
  • Ischemia (complications, surgery)
  • Leg (blood supply)
  • Lumbosacral Region
  • Male
  • Middle Aged
  • Popliteal Artery (physiopathology)
  • Prognosis
  • Prospective Studies
  • Sympathectomy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: